Hybrid Neuroscience Nursing Annual Conference

Saturday, March 12 - Tuesday, March 15, 2022

Rising Together

2022 Pre-Conference Events

The following are extra-cost events, not included in the 2022 Neuroscience Nursing Annual Conference registration fee.

Linda 20188 am–12 pm MST
Level: Intermediate
Track: Anatomy
(002) 3D Brain and Spine Anatomy and Pathology
Speaker: Linda Littlejohns, MSN RN SCRN CNRN FAAN

If you have been puzzled by your patients’ symptoms and have wondered how to plan their care or discuss the problem with them, their family, or other healthcare team members, this session is for you. A sound knowledge of brain and spine anatomy is essential for neuroscience nursing practice, and the 3D Anatomage program is invaluable in answering all your questions as we discuss stroke, trauma, and degenerative diseases. 

Blissitt1-3 pm MST
Level: Intermediate
Track: Neurocritical Care
(003) Pulmonary Complications in Critically Ill Neuroscience Patients: Current Management Strategies

Pulmonary complications after neurologic illness and injury are common. Respiratory complications result in secondary neurologic injury, prolonged hospitalization, and worse outcomes. This presentation will include a brief discussion of each of the pulmonary complications, including mechanisms and pathophysiology, and strategies to minimize or lessen the related respiratory disorders. Current management strategies as well as the evidence and controversies surrounding these strategies will be elucidated. Case studies will be included to enhance learning.

Mary Decker Mentorship Pat Zrelak1–3 pm MST
Level: Intermediate
Track: Cerebrovascular/Stroke
(004) Learnings from the Early Adoption of Tenecteplase From a Large Integrated Medical System
Course Director: Patricia Zrelak, PhD RN CNRN NEA-bc SCRN PHN FAHA

Approved in 1996, intravenous (IV) alteplase remains the only FDA-approved pharmaceutical treatment of acute ischemic stroke. Multiple recent studies comparing tenecteplase and alteplase suggest that tenecteplase is at least as efficacious as alteplase with regards to neurologic improvement with other suggestive clinical advantages. In this talk, the presenters will discuss their planning and implementation experience for implementing IV tenecteplase as the first line pharmaceutical treatment for acute ischemic stroke from a nursing perspective, as well as major outcomes, so that others can learn from their work.

AANN is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. All CE contact hours are subject to change as the Annual Conference approaches.